Diverse morphological responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1
- PMID: 3495854
- DOI: 10.1007/BF00267340
Diverse morphological responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1
Abstract
Supernatant media from cultured human mononuclear blood leukocytes (MCCM) induced morphological changes in normal human synovial fibroblasts in culture, including the formation of cells with a dendritic or stellate morphology and, less frequently, cells with a striking fenestrated appearance. These changes were fully reversed within 1 h of removing the MCCM. They were inhibited by indomethacin, the glucocorticoids hydrocortisone, prednisolone and dexamethasone, and by colcemid, but not by actinomycin D and only weakly by cycloheximide. The morphological responses to MCCM could be reproduced by MCCM fractions containing interleukin 1-like activity and by purified forms of human interleukin 1 (IL-1), including monocyte-derived IL-1 beta and recombinant IL-1 alpha. These responses were also inhibited by indomethacin, indicating a link with prostanoid production. However, the morphological responses were not related to the stimulation of plasminogen activator activity due to MCCM, MCCM fractions, or IL-1.
Similar articles
-
Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.Arthritis Rheum. 1988 Aug;31(8):1046-51. doi: 10.1002/art.1780310817. Arthritis Rheum. 1988. PMID: 3136776
-
Interleukin 1 stimulation of synovial cell plasminogen activator production.J Rheumatol. 1986 Feb;13(1):15-9. J Rheumatol. 1986. PMID: 3486284
-
Evidence that interleukin-1 induction of synovial cell plasminogen activator is mediated via prostaglandin E2 and cAMP.Arthritis Rheum. 1986 Sep;29(9):1078-84. doi: 10.1002/art.1780290904. Arthritis Rheum. 1986. PMID: 3019358
-
Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.Arthritis Rheum. 1981 Oct;24(10):1296-303. doi: 10.1002/art.1780241010. Arthritis Rheum. 1981. PMID: 7197936
-
Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.Arthritis Rheum. 1992 Dec;35(12):1526-34. doi: 10.1002/art.1780351217. Arthritis Rheum. 1992. PMID: 1472130
Cited by
-
HIG-82: an established cell line from rabbit periarticular soft tissue, which retains the "activatable" phenotype.In Vitro Cell Dev Biol. 1988 Oct;24(10):1015-22. doi: 10.1007/BF02620875. In Vitro Cell Dev Biol. 1988. PMID: 2846503